Grant opportunity · RFA-NS-25-023
HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
Who can apply (as listed)
- Nonprofits without 501(c)(3) status (other than institutions of higher education)
- Native American tribal organizations (other than federally recognized governments)
- State governments
- County governments
- Others (see the opportunity text)
- Public and state-controlled institutions of higher education
- Private institutions of higher education
- Independent school districts
- For-profit organizations (other than small businesses)
- Special district governments
- Public housing authorities / Indian housing authorities
- City or township governments
- Nonprofits with 501(c)(3) status (other than institutions of higher education)
- Native American tribal governments (federally recognized)
- Small businesses
This funding opportunity is part of a suite of NOFOs within the NIH HEAL Initiative to support the development of safe, effective, and non-addictive therapeutics to treat pain. The goal is to encourage initial translational efforts that will support a drug discovery program and advance projects to the point where they meet the entry criteria for the Pain Therapeutics Development Program. The scope will therefore be focused on development of assays to support a distinct testing funnel, screening efforts to identify hits, and initial characterization of hits and potential therapeutic agents (including small molecules, biologics, and natural products).
Excerpt as published. The full synopsis, required forms, and any amendments are on the official listing.
GrantSet indexes public records and is not the official application channel. Responses and applications go through Grants.gov only — the official notice there controls if anything shown here differs.